Literature DB >> 9618901

Serotonergic innervation of the hypothalamic suprachiasmatic nucleus and photic regulation of circadian rhythms.

G E Pickard1, M A Rea.   

Abstract

Converging lines of evidence have firmly established that the hypothalamic suprachiasmatic nucleus (SCN) is a light-entrainable circadian oscillator in mammals, critically important for the expression of behavioral and physiological circadian rhythms. Photic information essential for the daily phase resetting of the SCN circadian clock is conveyed directly to the SCN from retinal ganglion cells via the retinohypothalamic tract. The SCN also receives a dense serotonergic innervation arising from the mesencephalic raphe. The terminal fields of retinal and serotonergic afferents within the SCN are co-extensive, and serotonergic agonists can modify the response of the SCN circadian oscillator to light. However, the functional organization and subcellular localization of 5HT receptor subtypes in the SCN are just beginning to be clarified. This information is necessary to understand the role 5HT afferents play in modulating photic input to the SCN. In this paper, we review evidence suggesting that the serotonergic modulation of retinohypothalamic neurotransmission may be achieved via at least two different cellular mechanisms: 1) a postsynaptic mechanism mediated via 5HT1A or 5ht7 receptors located on SCN neurons; and 2) a presynaptic mechanism mediated via 5HT1B receptors located on retinal axon terminals in the SCN. Activation of either of these 5HT receptor mechanisms in the SCN by specific 5HT agonists inhibits the effects of light on circadian function. We hypothesize that 5HT modulation of photic input to the SCN may serve to set the gain of the SCN circadian system to light.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9618901     DOI: 10.1016/s0248-4900(98)80007-5

Source DB:  PubMed          Journal:  Biol Cell        ISSN: 0248-4900            Impact factor:   4.458


  13 in total

1.  The neuropeptide Y Y5 receptor mediates the blockade of "photic-like" NMDA-induced phase shifts in the golden hamster.

Authors:  P C Yannielli; M E Harrington
Journal:  J Neurosci       Date:  2001-07-15       Impact factor: 6.167

2.  The SSRI citalopram increases the sensitivity of the human circadian system to light in an acute dose.

Authors:  E M McGlashan; L S Nandam; P Vidafar; D R Mansfield; S M W Rajaratnam; S W Cain
Journal:  Psychopharmacology (Berl)       Date:  2018-09-15       Impact factor: 4.530

Review 3.  Advances in tryptophan hydroxylase-2 gene expression regulation: new insights into serotonin-stress interaction and clinical implications.

Authors:  Guo-Lin Chen; Gregory M Miller
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2012-03       Impact factor: 3.568

4.  Glutamate blocks serotonergic phase advances of the mammalian circadian pacemaker through AMPA and NMDA receptors.

Authors:  R A Prosser
Journal:  J Neurosci       Date:  2001-10-01       Impact factor: 6.167

5.  5-HT1B receptor-mediated presynaptic inhibition of retinal input to the suprachiasmatic nucleus.

Authors:  G E Pickard; B N Smith; M Belenky; M A Rea; F E Dudek; P J Sollars
Journal:  J Neurosci       Date:  1999-05-15       Impact factor: 6.167

6.  Systematic review of drugs that modify the circadian system's phase-shifting responses to light exposure.

Authors:  Robert Lee; Austin McGee; Fabian-Xosé Fernandez
Journal:  Neuropsychopharmacology       Date:  2021-12-27       Impact factor: 8.294

7.  Long-term effects of neonatal alcohol exposure on photic reentrainment and phase-shifting responses of the activity rhythm in adult rats.

Authors:  Gregg C Allen; Yuhua Z Farnell; Ji-ung Maeng; James R West; Wei-Jung A Chen; David J Earnest
Journal:  Alcohol       Date:  2005-10       Impact factor: 2.405

8.  Setting the main circadian clock of a diurnal mammal by hypocaloric feeding.

Authors:  Jorge Mendoza; Sylviane Gourmelen; Stephanie Dumont; Dominique Sage-Ciocca; Paul Pévet; Etienne Challet
Journal:  J Physiol       Date:  2012-05-08       Impact factor: 5.182

Review 9.  Agomelatine: mechanism of action and pharmacological profile in relation to antidepressant properties.

Authors:  B Guardiola-Lemaitre; C De Bodinat; P Delagrange; M J Millan; C Munoz; E Mocaër
Journal:  Br J Pharmacol       Date:  2014-08       Impact factor: 8.739

10.  Circadian and dark-pulse activation of orexin/hypocretin neurons.

Authors:  Oliver J Marston; Rhîannan H Williams; Maria M Canal; Rayna E Samuels; Neil Upton; Hugh D Piggins
Journal:  Mol Brain       Date:  2008-12-03       Impact factor: 4.041

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.